{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:35:20Z","timestamp":1792708520427,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012433","name":"Key Project of Technological Innovation Application Development Plan of Chongqing City","doi-asserted-by":"publisher","award":["cstc2019jscx-gksbx0007"],"award-info":[{"award-number":["cstc2019jscx-gksbx0007"]}],"id":[{"id":"10.13039\/501100012433","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.canlet.2026.218481","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:13:07Z","timestamp":1775455987000},"page":"218481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["SLC28A1 inhibits clear cell renal cell carcinoma progression by affecting arachidonic acid metabolism: A novel nucleoside transporter-based targeted therapy strategy"],"prefix":"10.1016","volume":"649","author":[{"given":"Junwu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3416-8931","authenticated-orcid":false,"given":"Harsh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1332-6626","authenticated-orcid":false,"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.canlet.2026.218481_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European association of urology guidelines on renal cell carcinoma: the 2022 update","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur. Urol."},{"issue":"22","key":"10.1016\/j.canlet.2026.218481_bib2","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.3390\/cancers14225710","article-title":"Tat-hspb1 suppresses clear cell renal cell carcinoma (ccRCC) growth via lysosomal membrane permeabilization","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"31","key":"10.1016\/j.canlet.2026.218481_bib3","article-title":"Frequency, incidence and survival outcomes of clear cell renal cell carcinoma in the United States from 1973 to 2014: a SEER-based analysis","volume":"98","author":"Feng","year":"2019","journal-title":"Medicine (Baltim.)"},{"issue":"12","key":"10.1016\/j.canlet.2026.218481_bib4","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.3390\/cancers15123207","article-title":"Recent advances in the management of clear cell renal cell carcinoma: novel biomarkers and targeted therapies","volume":"15","author":"Schiavoni","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.canlet.2026.218481_bib5","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.3390\/cancers15184488","article-title":"Lifestyle and clinical factors in a nationwide stage III and IV renal cell carcinoma study","volume":"15","author":"Azawi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.canlet.2026.218481_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.32604\/or.2023.027942","article-title":"Review and prospect of immune checkpoint blockade therapy represented by PD-1\/PD-L1 in the treatment of clear cell renal cell carcinoma","volume":"31","author":"Ge","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.canlet.2026.218481_bib7","article-title":"Advances in immunotherapy and targeted therapy for advanced clear-cell renal cell carcinoma: current strategies and future directions","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218481_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/ijms26010265","article-title":"Innovative therapies targeting drug-resistant biomarkers in metastatic clear cell renal cell carcinoma (ccRCC)","volume":"26","author":"Abah","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2026.218481_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14099-0","article-title":"Vector-independent transmembrane transport of oligodeoxyribonucleotides involves p38 mitogen activated protein kinase phosphorylation","volume":"7","author":"Peng","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218481_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108300","article-title":"Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: potential therapeutic opportunities","volume":"240","author":"Kaur","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.canlet.2026.218481_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1389200043489162","article-title":"Mammalian nucleoside transporters","volume":"5","author":"Kong","year":"2004","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.canlet.2026.218481_bib12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3389\/fphar.2018.00606","article-title":"Emerging roles of nucleoside transporters","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218481_bib13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2174\/157016109789043892","article-title":"Nucleoside transporter proteins","volume":"7","author":"Molina-Arcas","year":"2009","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218481_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuint.2014.03.014","article-title":"Nucleoside transporters in the purinome","volume":"73","author":"Dos Santos-Rodrigues","year":"2014","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.canlet.2026.218481_bib15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/15257770802145819","article-title":"Physiological and pharmacological roles of nucleoside transporter proteins","volume":"27","author":"Molina-Arcas","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"4\u20136","key":"10.1016\/j.canlet.2026.218481_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/15257771003729823","article-title":"Role of nucleoside transporters in nucleoside-derived drug sensitivity","volume":"29","author":"Molina-Arcas","year":"2010","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"5","key":"10.1016\/j.canlet.2026.218481_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00424-003-1103-2","article-title":"The equilibrative nucleoside transporter family, SLC29","volume":"447","author":"Baldwin","year":"2004","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"6","key":"10.1016\/j.canlet.2026.218481_bib18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.leu.2402114","article-title":"Nucleoside analogues: mechanisms of drug resistance and reversal strategies","volume":"15","author":"Galmarini","year":"2001","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.canlet.2026.218481_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00428-015-1732-9","article-title":"Immunohistochemical distinction of metastases of renal cell carcinoma to the adrenal from primary adrenal nodules, including oncocytic tumor","volume":"466","author":"Li","year":"2015","journal-title":"Virchows Arch."},{"issue":"1","key":"10.1016\/j.canlet.2026.218481_bib20","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s42003-024-06478-x","article-title":"Single-cell transcriptional profiling of clear cell renal cell carcinoma reveals a tumor-associated endothelial tip cell phenotype","volume":"7","author":"Zvirblyte","year":"2024","journal-title":"Commun. Biol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218481_bib21","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.3390\/ijms21103412","article-title":"Reactive oxygen species, metabolic plasticity, and drug resistance inCancer","volume":"21","author":"Bhardwaj","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218481_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2049-3002-2-17","article-title":"Mitochondrial reactive oxygen species and cancer","volume":"2","author":"Sullivan","year":"2014","journal-title":"Cancer Metabol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218481_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.105","article-title":"ROS homeostasis and metabolism: a dangerous liaison in cancer cells","volume":"7","author":"Panieri","year":"2016","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.canlet.2026.218481_bib24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/ATVBAHA.106.126714","article-title":"Physiological roles of vascular nucleoside transporters","volume":"27","author":"L\u00f6ffler","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.canlet.2026.218481_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.ircmb.2021.04.001","article-title":"Reactive oxygen species and DNA damage response in cancer","volume":"364","author":"Renaudin","year":"2021","journal-title":"Int Rev Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.canlet.2026.218481_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1515\/BC.2008.031","article-title":"Cellular responses to reactive oxygen species-induced DNA damage and aging","volume":"389","author":"Bertram","year":"2008","journal-title":"Biol. Chem."},{"issue":"5","key":"10.1016\/j.canlet.2026.218481_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01333-19","article-title":"Arachidonic acid kills Staphylococcus aureus through a lipid peroxidation mechanism","volume":"10","author":"Beavers","year":"2019","journal-title":"mBio"},{"issue":"1\u20132","key":"10.1016\/j.canlet.2026.218481_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11010-006-9362-9","article-title":"Arachidonic acid hydroperoxide stimulates lipid peroxidation in rat liver nuclei and chromatin fractions","volume":"298","author":"Marmunti","year":"2007","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.canlet.2026.218481_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/ijms26010265","article-title":"Innovative therapies targeting drug-resistant biomarkers in metastatic clear cell renal cell carcinoma (ccRCC)","volume":"26","author":"Abah","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.canlet.2026.218481_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/cancers12020408","article-title":"Outcomes associated with first-line anti-PD-1\/PD-L1 agents vs. sunitinib in patients with sarcomatoid renal cell carcinoma: a systematic review and meta-analysis","volume":"12","author":"Buonerba","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218481_bib31","article-title":"Advances in immunotherapy and targeted therapy for advanced clear-cell renal cell carcinoma: current strategies and future directions","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218481_bib32","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.advnut.2023.05.007","article-title":"Serine metabolic reprogramming in tumorigenesis, tumor immunity, and clinical treatment","volume":"14","author":"Shunxi","year":"2023","journal-title":"Adv. Nutr."},{"issue":"13","key":"10.1016\/j.canlet.2026.218481_bib33","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.3390\/ijms26136013","article-title":"Targeting prostate cancer metabolism through transcriptional and epigenetic modulation: a multi-target approach to therapeutic innovation","volume":"26","author":"Espitia-P\u00e9rez","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.canlet.2026.218481_bib34","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/13543776.2017.1344216","article-title":"Targeted nanotechnologies for cancer intervention: a patent review (2010-2016)","volume":"27","author":"Pradeep","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"issue":"5","key":"10.1016\/j.canlet.2026.218481_bib35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/nano12050743","article-title":"Recent advancements in mitochondria-targeted nanoparticle drug delivery for cancer therapy","volume":"12","author":"Xu","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.canlet.2026.218481_bib36","article-title":"Nanoparticle drug delivery systems for synergistic delivery of tumor therapy","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218481_bib37","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3390\/pharmaceutics17101315","article-title":"Translational advances in lipid nanoparticle drug delivery systems for cancer therapy: current status and future Horizons","volume":"17","author":"Rachamala","year":"2025","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.canlet.2026.218481_bib38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1248\/cpb.c21-00961","article-title":"Biomimetic nanoparticle drug delivery systems to overcome biological barriers for therapeutic applications","volume":"70","author":"Fukuta","year":"2022","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"9","key":"10.1016\/j.canlet.2026.218481_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202676","article-title":"Intracellular formation of hemicyanine nanoparticle enhances tumor-targeting photoacoustic imaging and photothermal therapy","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.canlet.2026.218481_bib40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fonc.2018.00214","article-title":"Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel-Lindau-Deficient Renal Cancer","volume":"8","author":"Mel\u00e9ndez-Rodr\u00edguez","year":"2018","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218481_bib41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.eururo.2015.08.007","article-title":"Hypoxia, hypoxia-inducible transcription factors, and renal cancer","volume":"69","author":"Sch\u00f6del","year":"2016","journal-title":"Eur. Urol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218481_bib42","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jgg.2021.05.016","article-title":"Von Hippel-Lindau tumor suppressor pathways & corresponding therapeutics in kidney cancer","volume":"48","author":"Shulman","year":"2021","journal-title":"J Genet Genomics"},{"issue":"1","key":"10.1016\/j.canlet.2026.218481_bib43","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1007\/s12672-025-03695-6","article-title":"D-mannose suppresses HIF-1\u03b1 mediated metabolic reprogramming in clear cell renal cell carcinoma","volume":"16","author":"Tian","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.canlet.2026.218481_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218244","article-title":"Amino acid metabolic reprogramming in clear cell renal cell carcinoma: pathogenic mechanisms and therapeutic targeting","volume":"640","author":"Xie","year":"2026","journal-title":"Cancer Lett."},{"issue":"13","key":"10.1016\/j.canlet.2026.218481_bib45","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.7150\/ijms.105969","article-title":"CLCN5 inhibits tumorigenesis and fatty acid accumulation in clear cell renal cell carcinoma by regulating enoyl CoA hydratase and 3-Hydroxyacyl CoA dehydrogenase","volume":"22","author":"Yu","year":"2025","journal-title":"Int. J. Med. Sci."},{"issue":"23","key":"10.1016\/j.canlet.2026.218481_bib46","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1158\/0008-5472.CAN-23-0969","article-title":"Fatty acid oxidation mediated by Malonyl-CoA decarboxylase represses renal cell carcinoma progression","volume":"83","author":"Zhou","year":"2023","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.canlet.2026.218481_bib47","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s11745-001-0812-7","article-title":"Polyunsaturated fatty acids, inflammation, and immunity","volume":"36","author":"Calder","year":"2001","journal-title":"Lipids"},{"key":"10.1016\/j.canlet.2026.218481_bib48","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fonc.2013.00224","article-title":"Current evidence linking polyunsaturated fatty acids with cancer risk and progression","volume":"3","author":"Azrad","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218481_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177924","article-title":"Reprogramming inflammation: mechanisms and therapeutic targeting of eicosanoids and pro-resolving mediators","volume":"1003","author":"Kolawole","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218481_bib50","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","article-title":"Regulation of ferroptosis by lipid metabolism","volume":"33","author":"Pope","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218481_bib51","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","article-title":"Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects","volume":"33","author":"Dierge","year":"2021","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.canlet.2026.218481_bib52","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3390\/biom14050555","article-title":"Defining a water-soluble formulation of arachidonic acid as a novel ferroptosis inducer in cancer cells","volume":"14","author":"Day","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.canlet.2026.218481_bib53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0006-291X(02)00919-1","article-title":"Cell-cycle-dependent regulation of CNT1, a concentrative nucleoside transporter involved in the uptake of cell-cycle-dependent nucleoside-derived anticancer drugs","volume":"296","author":"Vald\u00e9s","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2 Pt 1","key":"10.1016\/j.canlet.2026.218481_bib54","doi-asserted-by":"crossref","first-page":"C707","DOI":"10.1152\/ajpcell.1997.272.2.C707","article-title":"Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1)","volume":"272","author":"Ritzel","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.canlet.2026.218481_bib55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40164-019-0144-y","article-title":"A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker","volume":"8","author":"Wang","year":"2019","journal-title":"Exp. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218481_bib56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/jhep.2000.9546","article-title":"Selective loss of nucleoside carrier expression in rat hepatocarcinomas","volume":"32","author":"Dragan","year":"2000","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.canlet.2026.218481_bib57","first-page":"203","article-title":"The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy","volume":"8","author":"Lane","year":"2010","journal-title":"J. Exp. Therapeut. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218481_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/cells11020189","article-title":"Risk alleles for multiple myeloma susceptibility in ADME genes","volume":"11","author":"Scionti","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.canlet.2026.218481_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.173","article-title":"Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner","volume":"4","author":"P\u00e9rez-Torras","year":"2013","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.canlet.2026.218481_bib60","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/ijms24021353","article-title":"The phospholipase A2 superfamily: structure, isozymes, catalysis, physiologic and pathologic roles","volume":"24","author":"Khan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218481_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115034","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters hepatic polyunsaturated fatty acid metabolism and eicosanoid biosynthesis in female Sprague-Dawley rats","volume":"398","author":"Doskey","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218481_bib62","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1186\/s12864-023-09825-0","article-title":"Multi-omics analysis of functional substances and expression verification in cashmere fineness","volume":"24","author":"Xu","year":"2023","journal-title":"BMC Genom."},{"issue":"1","key":"10.1016\/j.canlet.2026.218481_bib63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0014-5793(02)03413-0","article-title":"Phospholipase A(2) regulation of arachidonic acid mobilization","volume":"531","author":"Balsinde","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2026.218481_bib64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biocel.2015.10.022","article-title":"Cross-talk between TLR4 and PPAR\u03b3 pathways in the arachidonic acid-induced inflammatory response in pancreatic acini","volume":"69","author":"Mateu","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218481_bib65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/08923978409028602","article-title":"Regulation of the human polymorphonuclear leukocyte inflammatory response by inhibitors of arachidonic acid metabolism","volume":"6","author":"Yocum","year":"1984","journal-title":"J. Immunopharm."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:59:22Z","timestamp":1779533962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":65,"alternative-id":["S0304383526002442"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218481","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SLC28A1 inhibits clear cell renal cell carcinoma progression by affecting arachidonic acid metabolism: A novel nucleoside transporter-based targeted therapy strategy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218481"}}